Because it cannot be known at hospitalization what proportion of patients without pretransplant DM will resolve their hyperglycemia or will continue to require insulin after discharge, all these patients need ongoing education and support regarding hyperglycemia management. The gene discussed is INS; the disease is diabetes mellitus.